Dimethyl Fumarate
These highlights do not include all the information needed to use DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES. DIMETHYL FUMARATE delayed-release capsules, for oral use Initial U.S. Approval: 2013
074d2820-6cb4-437a-8f6f-a21cb0a8ee02
HUMAN PRESCRIPTION DRUG LABEL
Jul 13, 2021
MSN LABORATORIES PRIVATE LIMITED
DUNS: 650786952
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dimethyl Fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Dimethyl fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Dimethyl fumarate
Product Details
FDA regulatory identification and product classification information